(AGENPARL) – SILVER SPRING lun 12 giugno 2023 FDA has approved Linzess (linaclotide) capsules to treat functional constipation in pediatric patients…
Browsing: pediatric
(AGENPARL) – SILVER SPRING mer 17 maggio 2023 Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act…
(AGENPARL) – SILVER SPRING mer 17 maggio 2023 Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals…
(AGENPARL) – SILVER SPRING lun 24 aprile 2023 DPMH oversees quality initiatives which promote and necessitate the study of drug and…
(AGENPARL) – SILVER SPRING mer 12 aprile 2023 Certain surgical respirators, surgical masks, and pediatric face masks by O&M Halyard do…
(AGENPARL) – SILVER SPRING lun 10 aprile 2023 Dissemination of pediatric information resulting from pediatric studies done pursuant to FDAAA Fonte/Source:…
(AGENPARL) – SILVER SPRING gio 16 marzo 2023 On March 16, 2023, the Food and Drug Administration approved dabrafenib (Tafinlar, Novartis)…
(AGENPARL) – SILVER SPRING gio 30 giugno 2022 On This Page Date: November 9, 2022 Time: 8:30 AM – 4:15 PM…
(AGENPARL) – SILVER SPRING mar 28 giugno 2022 Commissioner’s Fellowship Program The Commissioner’s Fellowship Program affords health care professionals, scientists, and engineers…
(AGENPARL) – SILVER SPRING gio 23 giugno 2022 On June 22, 2022, the Food and Drug Administration granted accelerated approval to…